Stay updated on Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial page.

Latest updates to the Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial page
- Check7 days agoChange DetectedPage revision indicator updated from v3.6.2 to v3.6.3, signaling a new published version of the study page. This update appears to be routine maintenance or metadata refresh rather than a substantive content change.SummaryDifference0.0%

- Check14 days agoChange DetectedThe page revision tag was updated to v3.6.2, replacing the previous v3.6.0.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedNew navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment header formatting was updated; a Revision: v3.6.0 note was introduced, while older labeling like 'Verified' and 'Last known status was:' appears to have been removed as part of a formatting/metadata update.SummaryDifference1%

- Check35 days agoChange DetectedThe page's revision number was updated to v3.5.5, indicating a newer version of the entry and likely reflecting minor metadata updates or fixes rather than changes to the study details.SummaryDifference0.0%

- Check57 days agoChange Detected- The site revision has been updated from v3.5.3 to v3.5.4, representing a new build/version of the platform. - This background update does not modify the study information displayed on the page.SummaryDifference0.0%

- Check64 days agoChange DetectedThe location entry was updated from Taoyuan, Taiwan to Taoyuan City, Taiwan to reflect the precise municipal designation used for study sites. This clarifies the geographic information listed for participating locations.SummaryDifference0.0%

Stay in the know with updates to Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial page.